Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women

Clinical trial NCT00326248 · COMPLETED

Trial details

NCT number: NCT00326248
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nausea and Vomiting, Postoperative

Start date: 2006-03-01
Primary completion: 2006-07-01
Enrollment: 482

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.